Αποτελέσματα Αναζήτησης
Delivers positive pressure ventilation, either CPAP or BiPAP, to improve oxygenation, elimination of CO 2, reduce the work of breathing. Delivered via a tight-fitting nasal mask, face (oro-nasal) mask or helmet. A good seal is necessary to deliver the desired positive pressure.
Keywords: telemedicine, oxygen therapy, noninvasive positive airway pressure, BiPAP, osteopathic medicine, physical therapy, SARS-CoV-2, COVID-19, teletherapy, telemanagement. Introduction. COVID-19 has become a global pandemic that has had a gross dramatic impact on hospitals and health care systems worldwide [1-3].
17 Ιουλ 2020 · CPAP is the method of choice with the use of BiPAP for those with complex respiratory conditions who contract COVID-19. The use of High Flow Nasal Oxygen (HFNO) remains contentious with different perspectives in how this modality can be used to treat respiratory failure in COVID-19.
8 Οκτ 2020 · For adults with COVID-19 and acute hypoxemic respiratory failure despite conventional oxygen therapy, the Panel recommends high-flow nasal cannula (HFNC) oxygen over noninvasive positive pressure ventilation (NIPPV) (BI).
WHO suggests that hospitalized patients with severe or critical COVID-19 with acute hypoxaemic respiratory failure that do not require emergent intubation be treated with HFNO, or CPAP or NIV (BiPAP) rather than standard oxygen therapy. www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2. Summary of findings for HFNO vs SOT comparison.
11 Σεπ 2024 · Respiratory support can include oxygenation with low-flow and high-flow systems, noninvasive ventilation (NIV), and other adjunctive therapies (eg, nebulized medications, prone positioning, etc). While many patients improve and respiratory support can be de-escalated, a proportion continue to deteriorate, and a decision needs to be made ...
28 Σεπ 2023 · The results of our network meta-analysis suggest that noninvasive ventilation, high-flow nasal oxygen, and conventional oxygen therapy are comparable in terms of treatment failure and mortality outcomes in COVID-19-associated acute respiratory failure.
